Olstein Capital Management L.P. Has $1.29 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Olstein Capital Management L.P. trimmed its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 42.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,000 shares of the company's stock after selling 11,000 shares during the period. Olstein Capital Management L.P.'s holdings in Prestige Consumer Healthcare were worth $1,290,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. increased its position in shares of Prestige Consumer Healthcare by 5.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock valued at $49,667,000 after purchasing an additional 33,844 shares during the period. Norges Bank acquired a new stake in Prestige Consumer Healthcare during the fourth quarter worth $40,009,000. BNP Paribas Financial Markets boosted its stake in Prestige Consumer Healthcare by 1,073.3% during the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock worth $15,923,000 after buying an additional 186,524 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Prestige Consumer Healthcare by 3.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company's stock valued at $126,274,000 after buying an additional 49,331 shares during the period. Finally, Principal Financial Group Inc. raised its stake in shares of Prestige Consumer Healthcare by 3.2% in the 4th quarter. Principal Financial Group Inc. now owns 256,526 shares of the company's stock valued at $20,032,000 after buying an additional 7,890 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on PBH. Oppenheimer lifted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Finally, Royal Bank of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

PBH stock traded down $0.04 during trading on Thursday, hitting $85.08. 278,537 shares of the stock traded hands, compared to its average volume of 299,363. Prestige Consumer Healthcare Inc. has a one year low of $63.79 and a one year high of $90.04. The company has a 50 day simple moving average of $83.61 and a 200 day simple moving average of $82.56. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock has a market cap of $4.20 billion, a price-to-earnings ratio of 19.93, a P/E/G ratio of 2.69 and a beta of 0.45.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. The company had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The company's revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.02 earnings per share. Equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.